| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 36,594 | 37,783 | 39,240 | 37,160 | | Cost of Revenue | 18,816 | 20,016 | 19,664 | 18,545 | | | Gross Profit | 17,778 | 17,767 | 19,576 | 18,615 | | | Operating Expenses | | Research Development | 2,246 | 2,131 | 2,253 | 2,408 | | Selling General and Administrative | 11,580 | 12,609 | 15,327 | 12,443 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,952 | 3,027 | 1,996 | 3,764 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 36 | 100 | 59 | (294) | | Earnings Before Interest And Taxes | 3,988 | 3,127 | 2,055 | 3,470 | | Interest Expense | 357 | 1,862 | 1,081 | (1,461) | | Income Before Tax | 3,631 | 1,265 | 974 | 4,931 | | Income Tax Expense | 918 | 689 | 343 | 1,399 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,713 | 576 | 631 | 3,532 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,713 | 576 | 631 | 3,532 | | Preferred Stock And Other Adjustments | (2,325) | (2,287) | (2,249) | (2,259) | | | Net Income Applicable To Common Shares | $388 | ($1,711) | ($1,618) | $1,273 |
|
0.17% Nasdaq 
Income Statement
